• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24124 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2006     NIHR Horizon Scanning Centre (NIHR HSC) Optiscope for internal examinations and surgical operations: horizon scanning technology note
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2000     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices for the detection of cervical cancer - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices in screening for cervical cancer - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic low vision aids for the visually impaired - horizon scanning review
2023     Agency for Care Effectiveness (ACE) Optune for the treatment of newly diagnosed and recurrent glioblastoma
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2001     NIHR Horizon Scanning Centre (NIHR HSC) Oral and buccal insulin for diabetes - horizon scanning review
2008     NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III
2003     University HealthSystem Consortium (UHC) Oral and intravenous antifungal agents - update (TCR)
2023     Institute for Clinical and Economic Review (ICER) Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value
2023     Institute for Clinical and Economic Review (ICER) Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value
2023     Austrian Institute for Health Technology Assessment (AIHTA) Oral and parenteral preexposure prophylaxis (PrEP) to prevent HIV in people at risk: a systematic review of clinical effectiveness and safety with assessment of organisational, economic, patient/social, ethical and legal elements
2017     Penn Medicine Center for Evidence-based Practice (CEP) Oral antibiotics for secondary prophylaxis following two-stage revision surgery for prosthetic joint infection
2022     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Oral anticoagulants for prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation. [Protocol]
2017     NIHR Health Technology Assessment programme Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis
2023     Swiss Federal Office of Public Health (FOPH) Oral anticoagulants for the prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation
2009     Medical Advisory Secretariat (MAS) Oral appliances for obstructive sleep apnea: an evidence-based analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral appliances for treatment of snoring and obstructive sleep apnea: a review of clinical-effectiveness
2022     National Institute for Health and Care Excellence (NICE) Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy. NICE technology appraisal guidance 827
2010     NIHR Horizon Scanning Centre (NIHR HSC) Oral calcitonin for osteoarthritis of the knee in men and postmenopausal women - first line
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral care sponges for long-term care patients: a review of the clinical-effectiveness
2014     Belgian Health Care Knowledge Centre (KCE) Oral cavity cancer: diagnosis, treatment and follow-up
2022     WorkSafeBC Oral collagen supplements for shoulder sprain strain
2013     Agency for Healthcare Research and Quality (AHRQ) Oral contraceptive use for the primary prevention of ovarian cancer
2019     Agency for Care Effectiveness (ACE) Oral COX-2 inhibitors for treating pain
2011     Agency for Healthcare Research and Quality (AHRQ) Oral diabetes medications for adults with type 2 diabetes: an update
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral endotracheal tube placement in neonates, pediatric, and adult patients: a review of the guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral ginger for the management of chemotherapy-induced nausea and vomiting in pediatric patients: clinical effectiveness and safety
2021     Penn Medicine Center for Evidence-based Practice (CEP) Oral hygiene interventions to prevent ventilator-associated pneumonia (VAP)
1993     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Oral implantology. Current state of knowledge
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Oral implants II - systematic review, expert panel
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral lidocaine for reflux or mucositis: clinical evidence and guidelines
2014     Agency for Healthcare Research and Quality (AHRQ) Oral mechanical bowel preparation for colorectal surgery
2007     NIHR Health Technology Assessment programme Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral nutrition intake for the prevention of falls in older adults: clinical effectiveness and guidelines
2022     NIHR Health Technology Assessment programme Oral nutritional interventions in frail older people who are malnourished or at risk of malnutrition: a systematic review
2003     Centre for Clinical Effectiveness (CCE) Oral or intravenous cyclophosphamide for patients with systemic lupus erythematosus?
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral progesterone for the treatment of menopausal symptoms: clinical evidence
2015     Penn Medicine Center for Evidence-based Practice (CEP) Oral rehydration therapy for adults with acute infectious gastrointestinal disease
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2018     NIHR Health Technology Assessment programme Oral steroids for hearing loss associated with otitis media with effusion in children aged 2 8 years: the OSTRICH RCT
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral topotecan (Hycamtin) for small cell lung cancer: horizon scanning technology briefing
2000     ECRI Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain
2001     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Oral treatment of psoriasis - primary research
2019     NIHR Health Technology Assessment programme Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
2014     Penn Medicine Center for Evidence-based Practice (CEP) Oral versus intravenous antibiotics for pediatric oncology patients with fever
2007     Adelaide Health Technology Assessment (AHTA) OraSure HIV point of care testing
2006     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Orchiectomy versus medical therapy with LH-RH analogues for the treatment of advanced prostatic carcinoma
2004     University HealthSystem Consortium (UHC) Oregovomab
2024     Agency for Care Effectiveness (ACE) Organ Care System (OCS) Heart System for heart transplantation of marginal brain-death donor hearts or circulatory-death donor hearts
2019     Norwegian Institute of Public Health (NIPH) Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Organic acid testing for autism: a review of the diagnostic accuracy
2010     Belgian Health Care Knowledge Centre (KCE) Organisation and financing of chronic dialysis in Belgium
2013     Belgian Health Care Knowledge Centre (KCE) Organisation of aftercare for patients with severe burn injuries
2014     Belgian Health Care Knowledge Centre (KCE) Organisation of care for adults with a rare or complex cancer
2012     Belgian Health Care Knowledge Centre (KCE) Organisation of care for chronic patients in Belgium: development of a position paper
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Organisation of services for diabetic retinopathy screening: HTA Advice 1: Organisation of services for diabetic retinopathy screening: Understanding HTBS Advice: Diabetic retinopathy screening in Scotland
2014     NIHR Health Services and Delivery Research programme Organisational interventions to reduce length of stay in hospital: a rapid evidence assessment
2025     NIHR Health and Social Care Delivery Program Organising general practice for care homes: a multi-method study
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Organizational and Economic Issues in the Management of Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI)
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Organizational and economic issues in the management of patients with acute ST-segment elevation myocardial infarction (STEMI)
2022     Penn Medicine Center for Evidence-based Practice (CEP) Organizational strategies to improve or promote healthcare worker wellness
1999     Health Council of the Netherlands Gezondheidsraad (GR) Organo-psycho syndrome (OPS): limits for exposure to solvents
2013     NIHR Horizon Scanning Centre (NIHR HSC) OrganOx® metra™ for liver preservation during transplantation
1999     Wessex Institute for Health Research and Development (WIHRD) Orlistat for the treatment of obesity
2013     NIHR Horizon Scanning Centre (NIHR HSC) Orteronel for metastatic hormone-relapsed prostate cancer following chemotherapy
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Orthodontic retainers
2007     Belgian Health Care Knowledge Centre (KCE) Orthopaedic appliances in Belgium: Health Technology Assessment
2016     Andalusian Health Technology Assessment Area (AETSA) Orthoses indication in foot deformities in children.
2023     Scottish Health Technologies Group (SHTG) Orthotic bracing for the treatment of idiopathic scoliosis in children and young people (less than 18 years)
2012     HAYES, Inc. Orthotic compression bracing for treatment of pectus carinatum
2016     NIHR Health Technology Assessment programme Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: systematic review, qualitative study, survey and costing analysis
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Orthotics and prosthetics workforce planning
2021     Health Technology Wales (HTW) Oscillating positive expiratory pressure devices for airway clearance in chronic hypersecretory lung conditions
2004     Norwegian Knowledge Centre for the Health Services (NOKC) Oseltamivir (Tamiflu (R)) for the prevention and treatment of influenza during an influenza pandemic
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Oseltamivir for the treatment of suspected influenza: a clinical and economic assessment
2008     National Institute for Health and Care Excellence (NICE) Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza. NICE technology appraisal guidance 158
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2025     National Institute for Health and Care Excellence (NICE) Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection. NICE technology appraisal guidance 1043
2022     National Institute for Health and Care Excellence (NICE) Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection. NICE technology appraisal guidance 761
2022     Agency for Care Effectiveness (ACE) Osimertinib for treating EGFR mutation-positive non-small-cell lung cancer
2020     National Institute for Health and Care Excellence (NICE) Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer. NICE technology appraisal guidance 653
2020     National Institute for Health and Care Excellence (NICE) Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer. NICE technology appraisal guidance 654
2025     National Institute for Health and Care Excellence (NICE) Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer. NICE technology appraisal guidance 1060
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ospemifene for vulvo-vaginal atrophy in postmenopausal women
2000     Alberta Heritage Foundation for Medical Research (AHFMR) OssaTron (R) extracorporeal shock wave device
2013     NIHR Horizon Scanning Centre (NIHR HSC) OssDsign™ Cranio PSI for skull repair
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2022     The Regional Health Technology Assessment Centre (HTA-centrum) Osseointegrated upper limb prostheses with and without neuromuscular control: benefits and risks
2003     Medical Services Advisory Committee (MSAC) OSTASE immunoassay for the mass measurement of serum bone alkaline phosphatase
2001     Wessex Institute for Health Research and Development (WIHRD) Osteo-odonto-keratoprosthesis as a treatment for severe corneal opacities
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Osteoarthritis treatment with Hyalgan - an HTA
2007     HAYES, Inc. Osteochondral allograft for articular disorders of the ankle
2013     HAYES, Inc. Osteochondral allograft transplantation for articular disorders of the ankle
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)